Resources | NITAG RESOURCE CENTER

2012 ∙ KRAR

NITAG statement on introduction of varicella in June 2012

2012 ∙ ACIP

FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella

2011 ∙ Farez, M. F. Correale, J.

Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis

2011 ∙ Chen, Q. Yang, X. Li, Y. He, X. Ma, X. Ma, L. Guo, Z. Li, L.

Preventive effects of Mycobacterium vaccae on HIV-associated tuberculosis: A systematic review

2011 ∙ ACIP

Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years

2010 ∙ Stuart Blume, Janneke Tump

Evidence and policymaking: The introduction of MMR vaccine in the Netherlands

2010 ∙ JCVI

JCVI Statement on varicella and herpes zoster vaccines - 29 March 2010

2010 ∙ NACI

NACI Statement on measles-mumps-rubella-varicella vaccine - September 2010

2010

Statement on minimum information requirements to advertise the Priorix® vaccine against measles-mumps-rubella

2010

Statement on minimum information requirements to advertise the Vax Pro® vaccine against measles-mumps-rubella